Another, more immediately available possibility for the treatment of COVID-19 is production of a hyper-IVIG from the plasma of COVID-19 convalescent donors (CoVIg-19), and developmental work is currently under way through a large alliance of plasma stakeholders (https://www.covig-19plasmaalliance.org).